CRH Medical Corporation is a Canada-based healthcare products and services company. The Company focused on providing physicians with services and products for the treatment of gastrointestinal diseases. The Company also provides anesthesiology services to gastroenterologists in the United States through its subsidiaries. The Company specializes in the treatment of hemorrhoids utilizing its treatment protocol and technology. The Company's product distribution strategy focuses on physician education, patient outcomes, and patient awareness. The Company's CRH O'Regan System, platform that provides gastrointestinal is a single use, disposable, hemorrhoid banding technology for treating hemorrhoid grades I-IV. The Company distributes the CRH O'Regan System, treatment protocols, operational and marketing expertise as a package to physicians. The Company's subsidiary, Gastroenterology Anesthesia Associates, LLC, provides anesthesiology services for gastroenterology procedures.
Industry, Sector and Symbol:
Capitalization:- Market Cap: C$314.89 million
- Outstanding Shares: 73,919,000
Average Prices:- 50 Day Moving Avg: C$6.76
- 200 Day Moving Avg: C$8.62
- 52 Week Range: C$4.22 - C$12.35
P/E:- Trailing P/E Ratio: 22.66
- P/E Growth: 0.00
Sales & Book Value:- Annual Revenue: C$87.06 million
- Price / Sales: 3.62
- Book Value: C$0.85 per share
- Price / Book: 5.01
Profitability:- EBIDTA: C$43.76 million
- Net Margins: 14.65%
- Return on Equity: 10.02%
- Return on Assets: 7.88%
Misc:- Average Volume: 468,210 shs.
- Short Ratio: 6.63
Frequently Asked Questions for CRH Medical Corp (TSE:CRH)
What is CRH Medical Corp's stock symbol?
CRH Medical Corp trades on the Tornton Stock Exchange (TSX) under the ticker symbol "CRH."
When will CRH Medical Corp make its next earnings announcement?
Where is CRH Medical Corp's stock going? Where will CRH Medical Corp's stock price be in 2017?
7 brokerages have issued 12 month price targets for CRH Medical Corp's stock. Their forecasts range from C$6.00 to C$10.00. On average, they anticipate CRH Medical Corp's share price to reach C$7.75 in the next year. View Analyst Ratings for CRH Medical Corp.
Who are some of CRH Medical Corp's key competitors?
Some companies that are related to CRH Medical Corp include AGT Food and Ingredients (AGT), Crew Energy (CR), Acasta Enterprises (AEF), Canada Goose Holdings (GOOS), Alacer Gold Corp (ASR), DREAM Unlimited Corp (DRM), Rogers Sugar (RSI), Canaccord Genuity Group (CF), Theratechnologies (TH), Savaria (SIS), Bonterra Energy Corp (BNE), Sprott (SII), Sienna Senior Living (LW), Lundin Gold (LUG), AutoCanada (ACQ), Tamarack-Valley-Energy-Ltd (TVE), Trevali Mining Corp (TV) and Pengrowth Energy Corp (PGF).
Who are CRH Medical Corp's key executives?
CRH Medical Corp's management team includes the folowing people:
- Anthony F. Holler M.D., Independent Chairman of the Board
- Edward J. Wright, Chief Executive Officer, Director
- Richard K. Bear, Chief Financial Officer
- Jay Kreger, President of CRH Anesthesia Management
- David Johnson, Independent Director
- Bergein F. Overholt M.D., Independent Director
- Todd R. Patrick, Independent Director
- Ian A. Webb, Independent Director
How do I buy CRH Medical Corp stock?
Shares of CRH Medical Corp and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
What is CRH Medical Corp's stock price today?
One share of CRH Medical Corp stock can currently be purchased for approximately C$4.26.
MarketBeat Community Rating for CRH Medical Corp (TSE CRH)MarketBeat's community ratings are surveys of what our community members think about CRH Medical Corp and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for CRH Medical Corp (TSE:CRH) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | 4 Hold Ratings, 3 Buy Ratings |
| Consensus Rating: | Hold (Score: 2.43) |
| Consensus Price Target: | C$7.75 |
Analysts' Ratings History for CRH Medical Corp (TSE:CRH)
Show:
| Date | Firm | Action | Rating | Price Target | Details |
|---|
| 7/21/2017 | Royal Bank Of Canada | Lower Price Target | Sector Perform -> Outperform | C$8.50 -> C$6.00 |  |
| 7/18/2017 | TD Securities | Boost Price Target | Buy -> Hold | C$5.50 -> C$10.00 | |
| 7/14/2017 | Bloom Burton | Downgrade | Buy -> Accumulate | | |
| 7/17/2017 | National Bank Financial | Lower Price Target | | C$9.00 -> C$7.00 | |
| 7/14/2017 | Scotiabank | Downgrade | Outperform -> Sector Perform | C$10.00 -> C$8.00 | |
| 2/24/2017 | Beacon Securities | Reiterated Rating | Buy | | |
| 9/13/2016 | CIBC | Reiterated Rating | Outperform | | |
| 12/14/2015 | Acumen Capital | Lower Price Target | Speculative Buy | C$5.90 -> C$5.70 | |
(Data available from 7/26/2015 forward)
Earnings History for CRH Medical Corp (TSE:CRH)Earnings History by Quarter for CRH Medical Corp (TSE CRH)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 7/26/2017 | | $0.05 | | | | | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for CRH Medical Corp (TSE:CRH)2017 EPS Consensus Estimate: $0.36
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
| Q1 2017 | 1 | $0.08 | $0.08 | $0.08 |
| Q2 2017 | 2 | $0.04 | $0.09 | $0.07 |
| Q3 2017 | 1 | $0.10 | $0.10 | $0.10 |
| Q4 2017 | 1 | $0.11 | $0.11 | $0.11 |
(Data provided by Zacks Investment Research)
Dividend History for CRH Medical Corp (TSE:CRH)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for CRH Medical Corp (TSE:CRH)Insider Trades by Quarter for CRH Medical Corp (TSE:CRH)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 6/28/2017 | David Johnson | Director | Sell | 30,000 | C$5.67 | C$170,100.00 | |
| 3/21/2017 | Edward Wright | Director | Sell | 500,000 | C$11.05 | C$5,525,000.00 | |
| 3/3/2017 | David Johnson | Director | Sell | 25,000 | C$7.45 | C$186,250.00 | |
| 3/23/2016 | David Johnson | Director | Sell | 5,000 | C$3.36 | C$16,800.00 | |
| 12/3/2015 | Ian A Webb | Director | Sell | 2,800 | C$3.50 | C$9,800.00 | |
| 9/15/2015 | Edward Wright | Director | Sell | 500,000 | C$5.01 | C$2,502,500.00 | |
| 9/15/2015 | Richard Bear | Insider | Sell | 210,000 | C$3.77 | C$791,700.00 | |
| 5/28/2015 | David Johnson | Director | Buy | 10,000 | C$2.93 | C$29,300.00 | |
| 5/27/2015 | David Johnson | Director | Buy | 10,000 | C$2.93 | C$29,300.00 | |
| 5/26/2015 | David Johnson | Director | Buy | 10,000 | C$2.97 | C$29,700.00 | |
| 5/1/2015 | Bergein Overholt | Director | Buy | 10,000 | C$2.88 | C$28,800.00 | |
| 10/30/2014 | Fernbank Llc | Insider | Sell | 3,500 | C$0.76 | C$2,660.00 | |
(Data available from 1/1/2013 forward)
Headline Trends for CRH Medical Corp (TSE:CRH)
Latest Headlines for CRH Medical Corp (TSE:CRH)
| Source: |
|
CRH Medical Corp (CRH) Chart for Wednesday, July, 26, 2017
